Nexus Pharmaceuticals

Vernon Hills, United States Founded: 2003 • Age: 23 yrs Acquired By Pharmaceutical Associates
Injectable generic and specialty drugs are manufactured with innovative processes.

About Nexus Pharmaceuticals

Nexus Pharmaceuticals is a Healthcare company based in Vernon Hills (United States) founded in 2003, and was acquired by Pharmaceutical Associates in November 2026. Injectable generic and specialty drugs are manufactured with innovative processes. It operates on a Direct-to-Consumer (D2C) model. Its chief executive, as recorded, is Mariam Darsot. Nexus Pharmaceuticals offers products and services including EMERPHED® RTU. Its focus areas include Pharmaceuticals and Generic and Specialty Drugs. Its legal entity is Nexus Pharmaceuticals, LLC.

Company details

Nexus Pharmaceuticals, a US-based pharmaceutical manufacturer, is dedicated to the development and deployment of lifesaving, critical-need drugs. Operating in the generic and specialty injectable drug industry since 2003, the company addresses unmet medical needs by providing reliable treatment options. Their efforts are centered on ensuring that essential medications are available when and where they are most needed.

Key Metrics

Products & Services of Nexus Pharmaceuticals

Nexus Pharmaceuticals offers a comprehensive portfolio of products and services, including EMERPHED® RTU.

EMERPHED® RTU
Pharmaceuticals

Ephedrine sulfate injection is provided for emergency use.

Apps and channels of Nexus Pharmaceuticals

its YouTube channel Nexus Pharmaceuticals, LLC has 590 subscribers and 14 videos.

Nexus Pharmaceuticals, LLC
YouTube 590 subscribers 14 videos Science & Technology
Open channel

Videos from Nexus Pharmaceuticals

The most watched videos on Nexus Pharmaceuticals's YouTube channel, Nexus Pharmaceuticals, LLC (590 subscribers). Click a video to play it here.

Tour of Manufacturing Facility | Nexus Pharmaceuticals
55.8K views
Our Story | Nexus Pharmaceuticals
3.8K views
Project Tomorrow Grand Opening | Nexus Pharmaceuticals
2.4K views
The Story of Project Tomorrow | Nexus Pharmaceuticals
752 views

More on Nexus Pharmaceuticals, LLC.

Investors in Nexus Pharmaceuticals

Nexus Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Pharmaceutical Associates.

All
InvestorDescriptionFounded YearDomainLocation
Generic liquid drugs are manufactured by Pharmaceutical Associates.
1968paipharma.comGreenville, United States
Premium access

Investor details for Nexus Pharmaceuticals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Nexus Pharmaceuticals

14 people are tracked at Nexus Pharmaceuticals (8 in leadership, 6 in team).

NameRoleGroup
Mariam Darsot
CEOLeadership
Usman Ahmed
President and Chief Executive OfficerLeadership
Trenton Lovell
Senior Director, Sales, National Accounts And Trade RelationsLeadership
Lara S.
Director, Information TechnologyLeadership
Omair Ahmed
Chief Operating OfficerLeadership
Vince Lopiccolo
Vice President Sales MarketingLeadership
Dan Geffen
Senior Director, Sales, National Accounts And Trade RelationsLeadership
Chris Conroy
Director, National AccountsLeadership
Angie Amarei
Senior Manager, Quality ControlTeam
Richa Rayamajhi
Sr. Business Intelligence AnalystTeam
Chris Wilburn
Manager, Pricing & ContractsTeam
Rebecca Bianchi
Associate Lead/lab CoordinatorTeam
Legi Jacob
Manager, API And StabilityTeam
Dale Beninato
Senior Validation EngineerTeam
Premium access

Complete people profiles for Nexus Pharmaceuticals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Nexus Pharmaceuticals

3 dated milestones of Nexus Pharmaceuticals across 23 years, from founding to its latest funding, stage changes and deals.

  1. Founded Nexus Pharmaceuticals is founded.
  2. Exit Acquired by Pharmaceutical Associates.
  3. Exit Acquired by Pharmaceutical Associates.

Web traffic of Nexus Pharmaceuticals

The website of Nexus Pharmaceuticals (nexuspharma.net) receives about 3.5K visits a month.

  • Monthly visits
    3.5K

    ▲ 52.3% vs previous month

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Nexus Pharmaceuticals (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Nexus Pharmaceuticals

Nexus Pharmaceuticals was founded in 2003.

Nexus Pharmaceuticals is headquartered in Vernon Hills, United States. It is registered at Vernon Hills, Illinois, United States.

Mariam Darsot is the CEO of Nexus Pharmaceuticals, as recorded in our data.

Nexus Pharmaceuticals, a US-based pharmaceutical manufacturer, is dedicated to the development and deployment of lifesaving, critical-need drugs. Operating in the generic and specialty injectable drug industry since 2003, the company addresses unmet medical needs by providing reliable treatment options. Their efforts are centered on ensuring that essential medications are available when and where they are most needed.

Nexus Pharmaceuticals offers EMERPHED® RTU.

Nexus Pharmaceuticals has 1 investor. Key investors include Pharmaceutical Associates.

Nexus Pharmaceuticals operates through Nexus Pharmaceuticals, Llc.

Yes. Nexus Pharmaceuticals was acquired by Pharmaceutical Associates in November 2026.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available